Zura Bio
ZURA
41 hedge funds and large institutions have $93.3M invested in Zura Bio in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 4 reducing their positions, and 4 closing their positions.
425% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 4
207% more capital inflows, than outflows
Capital inflows: $12.6M | Capital outflows: $4.1M
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
8% more funds holding
Funds holding: 38 → 41 (+3)
2.63% more ownership
Funds ownership: 29.81% → 32.44% (+2.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
+$4.21M |
| 2 |
Logos Global Management
San Francisco,
California
|
+$2.83M |
| 3 |
Silverarc Capital Management
Boston,
Massachusetts
|
+$1.63M |
| 4 |
BlackRock
New York
|
+$1.16M |
| 5 |
Eisler Capital (US)
New York
|
+$668K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3M |
| 2 |
Eisler Capital (UK)
London,
United Kingdom
|
-$820K |
| 3 |
Nuveen
Charlotte,
North Carolina
|
-$141K |
| 4 |
HRT Financial
New York
|
-$83K |
| 5 |
State Street
Boston,
Massachusetts
|
-$30.5K |
ZURA Hedge Fund Activity: Q3 2023 in Review
41 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q3 2023, worth a combined $93.3M — down 11% from $105M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ZURA positions and 4 closed out — a net gain of 3 holders — while 21 added to existing stakes and 4 trimmed.
The largest buyer was Armistice Capital, adding an estimated $4.21M. The largest seller was Point72 Asset Management, cutting an estimated $3M.
- 41 institutional investors held Zura Bio (ZURA) as of Q3 2023, up from 38 in Q2 2023.
- Funds reported $93.3M of Zura Bio stock for Q3 2023, down 11% quarter-over-quarter.
- 7 funds opened new Zura Bio positions in Q3 2023 and 4 closed out, a net change of +3 holders.
- The largest Zura Bio buyer in Q3 2023 was Armistice Capital, an estimated $4.21M added.
- The largest Zura Bio seller in Q3 2023 was Point72 Asset Management, an estimated $3M sold.
Based on aggregated 13F filings for Q3 2023.